ATE413893T1 - Wundverband enthaltend komplexe von vanadat und organische verbindungen - Google Patents
Wundverband enthaltend komplexe von vanadat und organische verbindungenInfo
- Publication number
- ATE413893T1 ATE413893T1 AT03767966T AT03767966T ATE413893T1 AT E413893 T1 ATE413893 T1 AT E413893T1 AT 03767966 T AT03767966 T AT 03767966T AT 03767966 T AT03767966 T AT 03767966T AT E413893 T1 ATE413893 T1 AT E413893T1
- Authority
- AT
- Austria
- Prior art keywords
- vanadate
- organic compounds
- wound dressing
- containing complexes
- dressing containing
- Prior art date
Links
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical compound [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 title abstract 2
- 150000002894 organic compounds Chemical class 0.000 title 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 abstract 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 abstract 1
- 229940076850 Tyrosine phosphatase inhibitor Drugs 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000013110 organic ligand Substances 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Junction Field-Effect Transistors (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0229012A GB2396106B (en) | 2002-12-12 | 2002-12-12 | Wound dressings comprising enzyme inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413893T1 true ATE413893T1 (de) | 2008-11-15 |
Family
ID=9949580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03767966T ATE413893T1 (de) | 2002-12-12 | 2003-12-08 | Wundverband enthaltend komplexe von vanadat und organische verbindungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060165761A1 (de) |
| EP (1) | EP1569697B1 (de) |
| AT (1) | ATE413893T1 (de) |
| AU (1) | AU2003292389A1 (de) |
| DE (1) | DE60324704D1 (de) |
| GB (1) | GB2396106B (de) |
| WO (1) | WO2004052412A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0328157D0 (en) | 2003-12-04 | 2004-01-07 | Imp College Innovations Ltd | Compounds |
| US9463119B2 (en) * | 2007-01-18 | 2016-10-11 | Abigo Medical Ab | Wound dressing with a bacterial adsorbing composition and moisture holding system |
| US8008035B2 (en) | 2007-01-25 | 2011-08-30 | Roche Diagnostics Operations, Inc. | Enhancement of vanadium-containing phosphatase inhibitors |
| EP1949894B1 (de) * | 2007-01-25 | 2016-06-29 | Roche Diagnostics GmbH | Verstärkung von vanadiumhaltigen Phosphatasehemmern mit Polyole |
| DK3441054T3 (da) * | 2007-11-05 | 2020-11-09 | Abigo Medical Ab | Indretning til behandling af vaginal svampeinfektion |
| US8263115B2 (en) * | 2008-09-11 | 2012-09-11 | Abigo Medical Ab | Method and a product to reduce and treat problems associated with tinea pedis |
| US10893983B2 (en) | 2008-12-03 | 2021-01-19 | Abigo Medical Ab | Method for dressing a wound |
| GB201103898D0 (en) * | 2011-03-08 | 2011-04-20 | Univ Cardiff | Molecular targets for healing or treating wounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300496A (en) * | 1991-09-30 | 1994-04-05 | The University Of British Columbia | Complexed vanadium for the treatment of diabetes mellitus |
| GB9323884D0 (en) * | 1993-11-19 | 1994-01-05 | Eisai London Res Lab Ltd | Physiological modulation |
| US5871779A (en) * | 1994-01-18 | 1999-02-16 | Mount Sinai Hospital Corporation | Treatment of arthropathies with vanadate compounds or analogues thereof |
| US5741777A (en) * | 1995-10-31 | 1998-04-21 | Board Of Regents, The University Of Texas System | Modulation of wound contraction by blocking protein tyrosine phosphatase |
| US20020019412A1 (en) * | 1998-03-12 | 2002-02-14 | Henrik Sune Andersen | Modulators of protein tyrosine phosphatases (ptpases) |
-
2002
- 2002-12-12 GB GB0229012A patent/GB2396106B/en not_active Expired - Lifetime
-
2003
- 2003-12-08 WO PCT/GB2003/005336 patent/WO2004052412A1/en not_active Application Discontinuation
- 2003-12-08 AU AU2003292389A patent/AU2003292389A1/en not_active Abandoned
- 2003-12-08 DE DE60324704T patent/DE60324704D1/de not_active Expired - Lifetime
- 2003-12-08 US US10/538,315 patent/US20060165761A1/en not_active Abandoned
- 2003-12-08 AT AT03767966T patent/ATE413893T1/de not_active IP Right Cessation
- 2003-12-08 EP EP03767966A patent/EP1569697B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004052412A1 (en) | 2004-06-24 |
| AU2003292389A1 (en) | 2004-06-30 |
| GB0229012D0 (en) | 2003-01-15 |
| US20060165761A1 (en) | 2006-07-27 |
| EP1569697A1 (de) | 2005-09-07 |
| GB2396106A (en) | 2004-06-16 |
| GB2396106B (en) | 2006-11-15 |
| EP1569697B1 (de) | 2008-11-12 |
| DE60324704D1 (de) | 2008-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9701162D0 (sv) | New use II | |
| ATE316785T1 (de) | Jak-3 hemmer zur behandlung von allergischen störungen | |
| DE69717268D1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
| DE60130976D1 (de) | Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs | |
| DE69813241D1 (de) | Vielschichtiger wundverband | |
| AP2001002348A0 (en) | Metalloprotease inhibitors. | |
| DE69826695D1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| EA200701467A1 (ru) | Пирролидиновые ингибиторы иап (ингибиторов апоптоза) | |
| ATE399547T1 (de) | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia | |
| TR200200204T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi. | |
| ATE413893T1 (de) | Wundverband enthaltend komplexe von vanadat und organische verbindungen | |
| DE602004016831D1 (de) | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend | |
| DE60212613D1 (de) | Doxycyclin zur behandlung von akne | |
| DE69814444D1 (de) | Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation | |
| DE69229552T2 (de) | Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau | |
| DE69818510D1 (de) | Neue verbindungen | |
| ATE303989T1 (de) | Inhibitoren von serin proteasen | |
| DE602004031954D1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| DE60334830D1 (de) | Furin-hemmer zur behandlung von fibrose und narbenbildung | |
| DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
| SE0301883D0 (sv) | New use II | |
| ATE337004T1 (de) | Verwendung von mangafodipir zur behandlung der hepatozellularen insuffizienz | |
| ATE525071T1 (de) | Verbindngen zur hemmung der sap-bindung zur behandlung von osteoarthritis | |
| DK0669834T3 (da) | Anvendelse af topisk påført faktor Xlll til inhibering af blødning | |
| NO20004393L (no) | Anvendelse av CD137 for Õ fremme proliferering av perifere monocytter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |